Potential relief for refractory angina.

1. Nakagawa F, May M, Phillips A. Life expectancy living with HIV: recent estimates and future implications. Curr Opin Infect Dis 2013;26:17-25. 2. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505. 3. Thirty years of a disease: the end of AIDS? The Economist. June 2, 2011 (http://www.economist.com/node/18774722). 4. Centers for Disease Control and Prevention. Estimated HIV incidence in the United States, 2007–2010. HIV Surveillance Supplemental Report 2012. Vol. 17. No. 4 (http://go.usa.gov/p8P4). 5. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010;363:2587-99. 6. Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med 2012;367:411-22. 7. Marrazzo JM, Ramjee G, Richardson BA, et al. Tenofovirbased preexposure prophylaxis for HIV infection among African women. N Engl J Med 2015;372:509-18. 8. van der Straten A, Stadler J, Luecke E, Laborde N, Hartmann M, Montgomery ET. Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: the VOICE-C qualitative study in Johannesburg, South Africa. J Int AIDS Soc 2014;17:Suppl 2: 19146. 9. van der Straten A, Musarea P, Etima J, et al. Disclosure of PK drug results promotes open discourse on non-adherence during VOICE. Presented at the HIV Research for Prevention scientific meeting, Cape Town, South Africa, October 28–31, 2014. abstract. 10. The Declaration of Sentiments: Women’s Rights Convention in Seneca Falls, New York, 1848. U.S. Constitution Online (http://www.usconstitution.net/sentiments.html#sent).